Weigand, K.; Peschel, G.; Grimm, J.; Müller, M.; Höring, M.; Krautbauer, S.; Liebisch, G.; Buechler, C.
HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV. Biomedicines 2022, 10, 3152.
https://doi.org/10.3390/biomedicines10123152
AMA Style
Weigand K, Peschel G, Grimm J, Müller M, Höring M, Krautbauer S, Liebisch G, Buechler C.
HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV. Biomedicines. 2022; 10(12):3152.
https://doi.org/10.3390/biomedicines10123152
Chicago/Turabian Style
Weigand, Kilian, Georg Peschel, Jonathan Grimm, Martina Müller, Marcus Höring, Sabrina Krautbauer, Gerhard Liebisch, and Christa Buechler.
2022. "HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV" Biomedicines 10, no. 12: 3152.
https://doi.org/10.3390/biomedicines10123152
APA Style
Weigand, K., Peschel, G., Grimm, J., Müller, M., Höring, M., Krautbauer, S., Liebisch, G., & Buechler, C.
(2022). HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV. Biomedicines, 10(12), 3152.
https://doi.org/10.3390/biomedicines10123152